
Akumin AKU
Quarterly report 2023-Q3
added 12-12-2023
Akumin ROCE Ratio 2011-2026 | AKU
Annual ROCE Ratio Akumin
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 58.25 | 12.94 | 4.64 | 7.44 | 8.17 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 58.25 | 4.64 | 18.29 |
Quarterly ROCE Ratio Akumin
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.23 | 22.89 | -14.28 | -5.13 | -3.83 | 2.66 | 11.96 | 14.03 | 17.52 | 19.72 | 11.6 | 3.49 | 3.49 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 44.23 | -14.28 | 9.87 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
25.0 | $ 120.92 | 2.26 % | $ 36.8 B | ||
|
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 21.25 | -5.56 % | $ 231 M | ||
|
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M | ||
|
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | ||
|
CareDx, Inc
CDNA
|
-10.16 | $ 21.35 | -4.77 % | $ 1.14 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-236.6 | $ 1.54 | 5.14 % | $ 2.05 M | ||
|
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | ||
|
Castle Biosciences
CSTL
|
1.9 | $ 25.01 | 1.83 % | $ 695 M | ||
|
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
0.8 | $ 182.91 | 3.37 % | $ 9.07 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
8.93 | $ 195.47 | 0.87 % | $ 139 B | ||
|
Interpace Biosciences
IDXG
|
18.26 | $ 2.2 | - | $ 9.73 M | ||
|
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
116.53 | $ 516.55 | 0.17 % | $ 14.9 B | ||
|
Illumina
ILMN
|
-35.1 | $ 132.22 | -0.38 % | $ 21 B | ||
|
Myriad Genetics
MYGN
|
-105.22 | $ 5.14 | 2.8 % | $ 476 M | ||
|
Fulgent Genetics
FLGT
|
-6.52 | $ 16.27 | 0.87 % | $ 492 M | ||
|
NeoGenomics
NEO
|
-9.11 | $ 8.29 | 1.53 % | $ 1.06 B | ||
|
Neogen Corporation
NEOG
|
-51.22 | $ 9.59 | 3.73 % | $ 2.08 B | ||
|
Koninklijke Philips N.V.
PHG
|
6.33 | $ 29.86 | 4.28 % | $ 20 B | ||
|
Guardant Health
GH
|
440.3 | $ 89.43 | 4.35 % | $ 11.2 B | ||
|
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | ||
|
Precipio
PRPO
|
-8.25 | $ 28.81 | -0.66 % | $ 46.2 M | ||
|
Anixa Biosciences
ANIX
|
-77.18 | $ 2.84 | 0.18 % | $ 92.2 K | ||
|
Biomerica
BMRA
|
-125.14 | $ 2.16 | -1.82 % | $ 4.96 M | ||
|
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 119.43 | 3.33 % | $ 9.85 B | ||
|
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 270.96 | 1.73 % | $ 22.5 B | ||
|
Senseonics Holdings
SENS
|
-111.94 | $ 6.84 | 1.04 % | $ 285 M | ||
|
Celcuity
CELC
|
-171.24 | $ 122.9 | -1.88 % | $ 5.75 B | ||
|
Soleno Therapeutics
SLNO
|
2.09 | $ 52.64 | 0.12 % | $ 2.68 B | ||
|
Lantheus Holdings
LNTH
|
28.52 | $ 84.29 | 0.44 % | $ 5.69 B | ||
|
Neuronetics
STIM
|
-140.48 | $ 1.46 | 3.93 % | $ 96.3 M | ||
|
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 193.74 | 1.19 % | $ 21.5 B | ||
|
ENDRA Life Sciences
NDRA
|
-185.74 | $ 5.7 | 10.23 % | $ 4.49 M | ||
|
Thermo Fisher Scientific
TMO
|
14.5 | $ 527.97 | 2.32 % | $ 199 B | ||
|
National Research Corporation
NRC
|
161.47 | $ 18.26 | 3.63 % | $ 409 M |